Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus propofol for sedation during electrochemotherapy of breast cancer skin lesions
IRCT20240515061805N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in breast cancer and metastasis comparing Dexmedetomidine arm with Propofol arm (2 arms). Primary endpoints: NPS, Ramsay Sedation Score and 2 more. Started May 2024; status: completed.
02
Drugs
dexmedetomidinepropofol
03
Conditions
breast cancermetastasis
Beyond the preview
Go deeper on IRCT20240515061805N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240515061805N1.